國家聯合資源(00254.HK):上市覆核委員會聆訊於2020年1月15日舉行
格隆匯11月25日丨國家聯合資源(00254.HK)公佈,於2019年11月13日,公司以程序不公為由,就聯交所上市委員會之除牌決定向香港高等法院提交司法覆核許可申請。
司法覆核申請的依據是基於聯交所無視公司出席上市委員會聆訊和陳詞之要求,及在公司缺席情況下於2019年8月29日在上市委員會聆訊上作出將公司股份除牌之決定。
上市覆核委員會聆訊原訂於2020年1月8日舉行。公司已向上市覆核委員會提出進一步延期要求,而上市覆核委員會聆訊現訂於2020年1月15日舉行。
此外,公司股份繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.